We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Alzheimer’s disease, cerebrovascular disease, and the β-amyloid cascade.
- Authors
Honjo, Kie; Black, Sandra E; Verhoeff, Nicolaas P L G
- Abstract
Alzheimer’s disease (AD), considered the commonest neurodegenerative cause of dementia, is associated with hallmark pathologies including extracellular amyloid-β protein (Aβ) deposition in extracellular senile plaques and vessels, and intraneuronal tau deposition as neurofibrillary tangles. Although AD is usually categorized as neurodegeneration distinct from cerebrovascular disease (CVD), studies have shown strong links between AD and CVD. There is evidence that vascular risk factors and CVD may accelerate Aβ 40-42 production/ aggregation/deposition and contribute to the pathology and symptomatology of AD. Aβ deposited along vessels also causes cerebral amyloid angiopathy. Amyloid imaging allows in vivo detection of AD pathology, opening the way for prevention and early treatment, if disease-modifying therapies in the pipeline show safety and efficacy. In this review, we review the role of vascular factors and Aβ, underlining that vascular risk factor management may be important for AD prevention and treatment.
- Publication
The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2012, Vol 39, Issue 6, p712
- ISSN
0317-1671
- Publication type
Journal Article
- DOI
10.1017/s0317167100015547